Magnetic Ventures
Venture capitalActively deployingBoston · Seed–Series A · 4 people tracked
Investment thesis
Magnetic VC targets companies operating at the intersection of deep tech and life sciences, including software tools for drug discovery, artificial intelligence, machine learning, multi-omics, precision medicine, and tech-enabled healthcare services. The firm seeks exceptional science and extraordinary founders with fluency across biology, chemistry, software, and AI disciplines. With deep domain expertise in engineering, biology, genomics, and regulatory navigation, the firm supports companies from seed stage through commercialization, drawing on decades of experience in FDA interactions, business development, and scaling breakthrough technologies.
Source: firm website, verified Jul 21, 2026.
Team · 4 people
from the firm's websiteWhat they invest in
from 9 of 29 portfolio companiesBiotech ×5Healthtech ×5AI & Machine Learning ×4Digital Health ×4Medical Devices ×3Advanced Manufacturing ×1Deep Tech ×1Enterprise Software ×1
HQs:United States×6
Investments · 29 tracked
founders shown can be your intro pathEvidence-based immersive VR platform pioneering prescription digital therapeutics.
AppliedVR develops immersive therapeutic software using technology to deliver drug-free clinical treatments for patients. The company focuses on healthcare applications where traditional medical approaches have limitations.
Digital HealthHealthtechMedical DevicesLos Angeles, US
Matthew Stoudt(Co-Founder and CEO)Josh Sackman(Co-Founder and President)David Sackman(Chairman)
AI and machine learning platform for accelerating drug discovery and development in rare genetic and chronic diseases.
Deep Genomics develops biological foundation models and computational tools for drug discovery. The company combines AI model development with laboratory workflows to identify novel molecules and drug targets for pharmaceutical development.
AI & Machine LearningBiotech
Eclipsebio provides RNA biology expertise and analytical technologies for drug developers and researchers, offering AI-powered sequence design, nucleotide-level characterization, and sequencing-based assays across small oligonucleotides, small molecules targeting RNA, AI training data, and basic research applications.
AI & Machine LearningBiotechDeep Tech
RNA biology expertise platform providing AI-powered sequence design and sequencing-based analytics for drug development.
AI-powered translational platform for developing novel molecules to treat psychiatric disease.
Gilgamesh Pharmaceutical develops novel chemical entities for psychiatric disorders using medicinal chemistry and AI-powered translational platforms to design rapid-acting therapies targeting neurobiological mechanisms rather than symptom management. The company's pipeline spans depression, anxiety, addiction, and schizophrenia, with programs validated by AbbVie's acquisition of its first asset and partnerships with Columbia University and the National Institute on Drug Abuse.
AI & Machine LearningBiotechDigital HealthHealthtechNew York City, US
JONATHAN SPORN(Founder)inAndrew Kruegel(Founder)inDalibor Sames(Founder)inJonathan Sporn(Founder & CEO)
GroundGame.Health connects people with care coordinators to address social and health barriers through personalized, culturally tailored support. The company serves health plans, employers, and community organizations seeking to deliver localized social care and remove obstacles to health equity.
Digital HealthHealthtechSocial
Develops first-in-class drugs targeting dormant disseminated tumor cells to prevent cancer recurrence.
HiberCell develops therapeutic candidates targeting the Integrated Stress Response pathway to address treatment-resistant cancers, relapse, and metastasis. The company focuses on cancer patients who have experienced treatment resistance through novel drug development approaches.
BiotechMedical Devices
Julio Aguirre-Ghiso, Ph.D.(Co-Founder)
Intelligent deep-tech clinical research platform for designing and executing impactful clinical trials.
Paradigm Health operates a platform that increases patient access to clinical trials through a provider-facing infrastructure combined with AI-powered research technology. The company serves patients, healthcare providers, researchers, and study sponsors in the clinical research and life sciences industry.
AI & Machine LearningHealthtechMedical DevicesSaaS
Kent Thoelke(Founder and CEO)Jonathan Hirsch(Chief Strategy and Growth Officer)
Generative AI and structural proteomics platform for discovering undruggable targets through proximity-based medicines.
Active-graph machine learning combined with single-cell analysis for advancing therapeutic candidates.
Resilience is a contract development and manufacturing organization (CDMO) that manufactures complex pharmaceutical products and active pharmaceutical ingredients to broaden access to medicines and protect biopharmaceutical supply chains against disruption.
Advanced ManufacturingBiotechEnterprise SoftwareBlue Ash, US
William S. Marth(Chief Executive Officer)Robert Nelsen
Technology platform for transforming complex medicine manufacturing and distribution.
GroundGame.Health facilitates personalized, culturally tailored social care coordination for health plan members, employers, and consumers. The company combines care coordinators with technology to help people overcome barriers to healthcare and address social needs.
Digital HealthHealthtechImpact & Social Good
Technology-based patient engagement platform advancing health equity and reducing health disparities.
Cellular profiling and target discovery platform with epitope resolution.
Microfluidics and machine learning platform for discovering modulators of biomolecular condensates.
Antibody discovery and optimization platform for selectively inhibiting extracellular enzymes in inflammatory disease.
Generative AI platform for automating and expediting the IND application process and regulatory filings.
Board seats · per SEC filings · 3
what is this? ⓘ$36.2M raise · filed Dec 2025 · via Christine Aylward, Christine Benjamin Aylward, Christine Benjamin Aylward
$6M raise · filed Dec 2023 · via Christine Aylward
$11.4M raise · filed Dec 2023 · via Christine Aylward
Inferred from directors named on each company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does Magnetic Ventures invest at?
- Magnetic Ventures invests at the Seed, Series A stages.
- What is Magnetic Ventures's typical check size?
- Magnetic Ventures typically writes checks of $1M – $6M.
- What sectors does Magnetic Ventures focus on?
- Magnetic Ventures focuses on AI & Machine Learning, Biotech, Deep Tech, Digital Health, Medical Devices.
- Where is Magnetic Ventures located?
- Magnetic Ventures is headquartered in Boston, US.
Similar investors
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.
Khosla Ventures is a technology-focused investment firm that seeks companies leveraging disruptive technological advances to solve large-scale problems across multiple industries. The firm emphasizes proprietary technology, business model innovation, and early-stage, bold investments with unfair advantages.
An early-stage venture capital firm investing in technology founders building solutions across multiple sectors.